Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Capital Expenditures (2016 - 2026)

Insmed's Capital Expenditures history spans 16 years, with the latest figure at $3.5 million for Q1 2026.

  • Quarterly Capital Expenditures fell 65.44% to $3.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $26.0 million through Mar 2026, down 4.92% year-over-year, with the annual reading at $32.6 million for FY2025, 48.52% up from the prior year.
  • Capital Expenditures came in at $3.5 million for Q1 2026, down from $16.6 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $16.6 million in Q4 2025 to a low of $582000.0 in Q3 2022.
  • The 5-year median for Capital Expenditures is $3.5 million (2025), against an average of $4.8 million.
  • Year-over-year, Capital Expenditures soared 390.38% in 2023 and then tumbled 65.44% in 2026.
  • Insmed's Capital Expenditures stood at $4.7 million in 2022, then crashed by 54.1% to $2.2 million in 2023, then skyrocketed by 214.54% to $6.8 million in 2024, then skyrocketed by 144.96% to $16.6 million in 2025, then crashed by 79.02% to $3.5 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Capital Expenditures are $3.5 million (Q1 2026), $16.6 million (Q4 2025), and $2.4 million (Q3 2025).